FDA approved two milestone treatments - the first cell-based gene therapies to treat sickle cell disease in patients 12 years and older.
ITB HOLDINGS LLC
390 North Orange Avenue, Suite 2300
Orlando, FL 32801
United States
T: +1 855 389 7344
T: +1 855 510 2240
T: +44 800 610 1577
https://www.fda.itbhdg.com/
